BioCanRx

About BioCanRx

BioCanRx’s vision is to cure patients and enhance the quality of life of those living with cancer. We will do this by supporting world-class research in the area of biotherapeutics for cancer treatment, and by accelerating to the clinic the most promising cancer biotherapeutics designed to save lives and enable a better quality of life. Through an innovative, collaborative funding process BioCanRx is becoming a world-leader in the translation, manufacture and adoption of innovative cancer biotherapeutics for the benefit of all cancer patients.
YEAR FOUNDED:
2014
LEADERSHIP:
President and CEO: Stéphanie Michaud, PhD
Scientific Director: John Bell, PhD
Director, Scientific Affairs: Kelley Parato, PhD
Director, Communications, Marketing & Engagement: Nancy Boyle